Key Words: GWAS Ⅲ NCAM1 Ⅲ hypertrophy Ⅲ genomics I ncreased left ventricular (LV) mass, termed LV hypertrophy, occurs in 33% to 43% of blacks, 1 a prevalence that is double that of whites. 2 Blacks also exhibit more concentric remodeling than whites, a pattern of LV hypertrophy characterized by increased pressure load and risk of diastolic dysfunction. 3 LV mass (LVM), and wall thickness phenotypes used in estimating LVM, are genetically determined and have high heritabilities, 5,6 particularly in blacks. 7 We describe results of a 3-stage genome-wide association study (GWAS) for echocardiographically determined LVM, posterior wall thickness (PWT), intraventricular septal thickness (IVST), LV internal dimension (LVID), and relative wall thickness (RWT) (2ϫPWT/LVID) in 2 hypertensive-ascertained family studies. Stages I and II were performed in blacks from HyperGEN (Hypertension Genetic Epidemiology Network) 8 and GENOA (Genetic Epidemiology Network of Atherosclerosis). 9,10 Stage III was performed in HyperGEN white families.
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lected using the same protocol in both studies. Genetic data for all stages were obtained via the Affymetrix 6.0 array for 1264 black and 1358 white HyperGEN and 989 GENOA participants.
All 5 phenotypes were log-transformed. Principal components to adjust for population substructure were generated in Eigenstrat. 11 Analyses were conducted in 2 steps using GRAMMER method. 12 SNPs with a probability value of Ͻ10
Ϫ6 from stage I were brought forward to stage II; SNPs with PϽ10 Ϫ7 from stage II were brought forward to stage III. Fisher combined probability test was used to calculate the metaanalytic probability value. 13 Table 2 ); the SNP is intragenic in the neural cell adhesion molecule 1 (NCAM1), and the minor allele frequency was 2.3% in blacks in both cohorts. The regional plot surrounding rs1436109 (stage I) is shown in Figure 1 ; although only rs1436109 passed our predetermined threshold, multiple SNPs within NCAM1 are associated with PWT. The only SNP tested in stage III was rs1436109; the variant allele frequency was 11.6% and the association remained for RWT (Pϭ5.47ϫ10 Ϫ4 ); rs1436109 was strongly associated with multiple phenotypes (ie, Fisher probability values for 3 stages combined:
Results
Ϫ3 , and LVIDϭ4.80ϫ10 Ϫ4 ).
Discussion
This is the first GWAS of echocardiographic phenotypes in hypertensive blacks and whites. We identified a novel locus, NCAM1, which explained 1.96% of variation in PWT in our discovery cohort. This same variant demonstrated consistent associations in the combined analysis of all 3 hypertensiveascertained cohorts with other measures of the LV (IVST, LVID, RWT) and mass (LVM/ht 2.7 ). NCAM1 is an abundant glycoprotein involved in cellcell and cell-matrix adhesion 15 that mediates adhesive interactions between cells in the nervous system and muscle. 16 Kimura et al 17 demonstrated in pulmonary hypertension-induced RV hypertrophy an increase in regional anatomic hyperinnervation that led to hyperfunctioning of cardiac sympathetic nerves, downregulation of neuronal cellular function, and an induction of fetal gene expression in sympathetic neurons. They suggested that "this phenomenon was explained by rejuvenation of cardiac sympathetic nerves as well as the hypertrophic cardiomyocytes, which also showed the fetal form gene expression." The results from this GWAS indicate NCAM1 is particularly relevant for increased LV wall thickness in the context of pressure overload (ie, hypertension), a condition highly prevalent in blacks. NCAM1 is also upregulated in myocytes in or adjacent to infarct regions and during remodeling in rat induced heart failure. 18, 19 Although NCAM1 may have no known direct functional involvement with our phenotypes, it is directly connected through biological interactions with numerous genes, many of which are expressed in cardiac tissue or have been shown to be functionally involved with cardiac phenotypes (Figure 2 ).
Non-standard Abbreviations and Acronyms

GWAS
genome-wide association study The NCAM1 SNP demonstrating the strongest association is in an 80-kb linkage disequilibrium block in intron 1. NCAM1 contains a large intron 1, and although the functional or regulatory significance of this SNP is unknown, intron 1 is known to contain more regulatory regions than other introns. 20 There are at least 4 transcription factor binding sites within 4 kb of rs1436109 that are conserved in humans, mouse, and rat, and 2 potential transcription factor binding sites contain our SNP. There are regulatory elements within 6 kb of rs1436109, as identified by DNase genomic footprinting and DNase I hypersensitivity clusters, histone modifications, enhancer-and promoter-associated histone markers, or transcription factor ChIP seq. Future work will require characterization of the functional relevance of NCAM1 for pressure overload LV hypertrophy.
Strengths and Limitations
This is the first GWAS of echocardiographic traits conducted initially in hypertensive blacks, a group at particularly high risk of LV hypertrophy and subsequent cardiovascular risk. We found 1 locus with strong statistical evidence in separate measures of wall thickness (IVST and PWT) and RWT. Given that hypertension is a potent "environmental" contributor to LV hypertrophy, it is plausible that hypertensiveprone families in HyperGEN contributed to our ability to detect genes that are susceptible to the effects of blood pressure on cardiac structure. HyperGEN and GENOA had identical echocardiography protocols, and readings were performed at a common reading center. We implemented a 3-stage design to reduce type I error. The family-based design reduces the potential for population stratification, and we corrected for admixture. One limitation is the low power to detect a significant stage II finding: we had 65% power to detect the observed effect and allele frequency assuming a probability value of 0.05. An additional limitation is the decreased genomic coverage of GWAS chips for black populations, which makes replication and genome-wide significant probability values more difficult to achieve. 21, 22 Given these limitations, the consistent, significant association of rs1436109 with PWT and correlated phenotypes is even more interesting.
Conclusions
We identified a novel locus that appears to be relevant for LV hypertrophy in hypertensive individuals. Although it is unlikely that the allelic effects observed in this study will be useful in the immediate future as clinical predictors of LV hypertrophy in individual patients, NCAM1 contributed to the burden of LV hypertrophy in these hypertensive blacks and whites. Further genetic studies to identify specific causal variants and functional studies can illuminate the mechanisms by which NCAM1 influences LV wall thickness. 
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